These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19246171)

  • 1. Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection.
    O'Rourke TR; Welsh FK; Tekkis PP; Lyle N; Mustajab A; John TG; Peppercorn D; Rees M
    Eur J Surg Oncol; 2009 Oct; 35(10):1085-91. PubMed ID: 19246171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
    Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
    Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
    Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
    J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
    Abdalla EK; Vauthey JN
    Dig Surg; 2008; 25(6):421-9. PubMed ID: 19212114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement.
    Hong HS; Byun JH; Won HJ; Kim KW; Lee SS; Lee MG; Yun SC
    Clin Radiol; 2010 Sep; 65(9):701-7. PubMed ID: 20696297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
    Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
    HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.
    Khan AZ; Morris-Stiff G; Makuuchi M
    J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
    Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
    AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferucarbotran-enhanced magnetic resonance imaging versus gadoxetic acid-enhanced magnetic resonance imaging for the preoperative detection of hepatocellular carcinoma: initial experience.
    Lee JY; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ
    J Comput Assist Tomogr; 2010 Jan; 34(1):127-34. PubMed ID: 20118735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinusoidal obstructive syndrome diagnosed with superparamagnetic iron oxide-enhanced magnetic resonance imaging in patients with chemotherapy-treated colorectal liver metastases.
    Ward J; Guthrie JA; Sheridan MB; Boyes S; Smith JT; Wilson D; Wyatt JI; Treanor D; Robinson PJ
    J Clin Oncol; 2008 Sep; 26(26):4304-10. PubMed ID: 18779617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
    Kulemann V; Schima W; Tamandl D; Kaczirek K; Gruenberger T; Wrba F; Weber M; Ba-Ssalamah A
    Eur J Radiol; 2011 Aug; 79(2):e1-6. PubMed ID: 20392584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
    Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
    Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
    AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of colorectal metastases in patients being treated with chemotherapy utilising SPIO-MRI: a radiological-pathological study.
    Smith JT; Ward J; Guthrie JA; Sheridan MB; Boyes S; Wilson D; Wyatt JI; Treanor D; Robinson PJ
    Magn Reson Imaging; 2012 Dec; 30(10):1446-53. PubMed ID: 22898686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Eur J Radiol; 2010 Jan; 73(1):131-6. PubMed ID: 18996659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.
    Shin NY; Kim MJ; Lim JS; Park MS; Chung YE; Choi JY; Kim KW; Park YN
    Eur Radiol; 2012 Apr; 22(4):864-71. PubMed ID: 22108766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis.
    Urdzik J; Bjerner T; Wanders A; Weis J; Duraj F; Haglund U; Norén A
    J Hepatol; 2012 Mar; 56(3):640-6. PubMed ID: 22027576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.
    Brouquet A; Benoist S; Julie C; Penna C; Beauchet A; Rougier P; Nordlinger B
    Surgery; 2009 Apr; 145(4):362-71. PubMed ID: 19303984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive factors for histopathological liver injury in the patients who received preoperative systemic chemotherapy for colorectal liver metastases].
    Kudo D; Tsutsumi S; Akasaka H; Jin H; Ohashi T; Muroya T; Hasebe T; Sakamoto Y; Ishido K; Koyama M; Toyoki Y; Murata A; Narumi S; Kijima H; Hakamada K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2025-7. PubMed ID: 20037312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.